Qureight 🇬🇧 Hiring · 6 open roles ↗
AI-powered imaging platform for clinical trials, analysing imaging and healthcare data for lung and heart diseases.
About Qureight
Qureight offers an AI-powered imaging platform designed for clinical trials, focusing on the analysis of imaging and healthcare data related to lung and heart diseases. Their technology includes automated image management, deep-learning biomarkers for tracking treatment responses, and access to extensive real-world data sets to enhance trial design and efficacy assessment.
Qureight is a UK-based company founded in 2018, now around 65 people. It has raised $31.2M in disclosed funding, starting with a Seed in 2022. FundFinder classes it as AI & ML.
Founded by Muhunthan Thillai (Co-Founder and CEO; previously Eastern Deanery, FDB UK; Imperial College London), Alessandro Ruggiero (Co-founder and CSO; previously Erasmus MC, Memorial Sloan Kettering Cancer Center; Cambridge Judge Business School).
Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.
Hiring now · 6 live roles, checked daily
Series B · Jul 2026
Guinness Ventures- Guinness Ventures — Guinness Ventures has invested into early stage businesses since 2010, providing capital to a wide range of UK companies · cheques £1M – £5M
Funding history
● rounds tracked in this directory · ○ earlier rounds web-verified from public announcements. Amounts as announced; undisclosed rounds omitted.